A phase 1 trial of the oral DNA methyltransferase inhibitor CC‐486 and the histone deacetylase inhibitor romidepsin in advanced solid tumorsStéphanie Gaillard, Nilofer S. Azad, Melinda Downs et al.|Cancer|2019Cited by 56
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025Nadeem R. Abu‐Rustum, Vaishnavi Sambandam, Susana M. Campos et al.|Journal of the National Comprehensive Cancer Network|2025Cited by 39
Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In OncologyNadeem R. Abu‐Rustum, Vaishnavi Sambandam, Susana M. Campos et al.|Journal of the National Comprehensive Cancer Network|2025Cited by 11